Literature DB >> 6371376

Clinicopathologic study of six cases of meningitis and meningoencephalitis in chimpanzees (Pan troglodytes).

H A Solleveld, M J van Zwieten, P J Heidt, P M van Eerd.   

Abstract

Three fatal cases of purulent meningitis and one fatal case of thromboembolic necrotizing meningoencephalitis occurred in chimpanzees from the Primate Center TNO, The Netherlands. In addition, two apes had clinical signs of meningitis and were successfully treated. The severity of the residual hemiparesis and dysphagia in one of these two apes was such that it was killed for humane reasons. The histopathological diagnosis was chronic active meningoencephalitis. Streptococcus pneumoniae was isolated from five apes and Klebsiella pneumoniae from one. In the majority of cases, the primary site of infection was the upper respiratory tract. After reducing the population density, initiating a vaccination program using a commercially available human polyvalent pneumococcal vaccine, and changing the cleaning procedure of the animal facilities, no other cases of meningitis or meningoencephalitis have occurred in the chimpanzee colony in the ensuing 3.5 years.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371376

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  3 in total

1.  New Streptococcus pneumoniae clones in deceased wild chimpanzees.

Authors:  Fang Chi; Michaela Leider; Fabian Leendertz; Carina Bergmann; Christophe Boesch; Svenja Schenk; Georg Pauli; Heinz Ellerbrok; Regine Hakenbeck
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

2.  Pathology Associated With Streptococcus spp. Infection in Baboons (Papio spp.).

Authors:  Katelin L Davis; Olga Gonzalez; Shyamesh Kumar; Edward J Dick
Journal:  Vet Pathol       Date:  2020-08-03       Impact factor: 2.221

3.  A new variant of the capsule 3 cluster occurs in Streptococcus pneumoniae from deceased wild chimpanzees.

Authors:  Dalia Denapaite; Regine Hakenbeck
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.